News and Events

  • February 1, 2013: Bone-Rad Therapeutics has named Craig Fortier as its new President and CEO. Mr. Fortier has worked in the Medical Device business for over 25 years, with much of that experience in start-up companies, and most recently served as Director of Strategic Marketing at Lumeins, the world’s largest medical laser manufacturer. Mr. Fortier replaces Steve Naber, who served as President and CEO from 2010-2012, and who will now serve as Bone-Rad's Chairman of the Board.
  • June 16, 2012: Drs. Kaneko, Keyak, Sehgal, and Skinner co-author a research article, entitled "Radioactive bone cement for the treatment of spinal metastases: a dosimetric analysis of clinical scenarios", in the peer-reviewed journal Physics in Medicine and Biology, the official journal of the International Organization for Medical Physics. [LINK]
  • May 26, 2011: Orange County Register: "What is O.C.'s next business superstar?" [LINK]
  • May 24, 2011: Bone-Rad Therapeutics is selected as one of twelve start-up companies to participate in the Investment Presentations at OCTANe's VC in the OC event, to be held at the Hyatt Regency in Irvine, CA. Additionally, please visit us during the event's OC Innovation Company Showcase.
  • May 17, 2011: Orange County Register: "'Real Housewives' mixing with venture capitalists" [LINK]
  • February 8, 2011: Bone-Rad Therapeutics invited to present at the Medical Technology Innovation Summit, to be held at the Medical Device & Manufacturing (MD&M) West Exposition and Conference in Anaheim, CA.
  • October 21, 2010: Bone-Rad Therapeutics has named Steve Naber as its new President and CEO. Mr. Naber has been involved with the financing and operations of start-up medical device companies for the past 20 years. Dr. Harry Skinner, the former President and CEO, will now serve as Bone-Rad's Chairman.
  • May 13, 2010: The research article published in Physics in Medicine and Biology is selected as a Featured Article and an Editor's Choice for the journal, and is profiled on MedicalPhysicsWeb in an article entitled "Model predicts dose from radioactive cement". [LINK]
  • April 26, 2010: Bone-Rad Therapeutics, Inc. and The University of California have signed a license agreement, giving Bone-Rad Therapeutics exclusive commercial rights to the radioactive bone cement technology being developed in Dr. Keyak's lab.
  • April 7, 2010: Drs. Kaneko, Keyak, Sehgal, and Skinner co-author a research article, entitled "Evaluation of a radiation transport modeling method for radioactive bone cement", in the peer-reviewed journal Physics in Medicine and Biology, the official journal of the International Organization for Medical Physics. [LINK]
  • January 14, 2010: The research behind radioactive bone cement, performed in Dr. Keyak's lab at UC Irvine, is featured as a Research Highlight by the Department of Defense (DOD) Congressionally Directed Medical Research Program. [LINK]
  • September 10, 2009: Orange County Register: "What Is Radioactive Bone Cement?" [LINK]
  • September 7, 2009: Dr. Keyak is named 10th on a list of the 25 Most Influential in Radiology, by RT-Image. [LINK]
  • February 13, 2009: Orthopaedic Research Society issues press release: "Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads"
  • December 1, 2008: Dr. Keyak is profiled by Today@UCI for her groundbreaking work in orthopaedic research, including the development of radioactive bone cement. [LINK]
  • September 19, 2008: Please join Bone-Rad Therapeutics, Inc. at the 10th SoCalBio Investor Conference at the Wilshire Grand Hotel in Los Angeles, California
  • June 5, 2008: Bone-Rad Therapeutics, Inc. is an exhibitor at BIOCOM DeviceFest 2008 in Costa Mesa, California
  • March 7, 2008: Bone-Rad Therapeutics, Inc. presents to the Board of Directors of the Don Beall Center for Innovation and Entrepreneurship at the University of California, Irvine
  • November 15, 2007: Bone-Rad Therapeutics, Inc. presents at the 2nd OCTANe California Medical Device Forum, in Costa Mesa, California
  • August 2, 2007: Bone-Rad Therapeutics, Inc. finalizes a letter agreement with the University of California, obtaining exclusive rights to license the patent for radioactive bone cement
  • June 19, 2007: Bone-Rad Therapeutics is certified as a C Corporation in the state of Delaware
  • June 12, 2007: Bone-Rad Therapeutics finalizes an engagement letter with Stradling Yocca Carlson & Rauth, Attorneys at Law, to provide legal counsel and representation
  • June 2007: Bone-Rad Therapeutics wins the UC Irvine Stradling Yocca Carlson and Rauth Business Plan Competition (University of California, Irvine, Paul Merage School of Business Alumni Newsletter) [LINK]
  • May 18, 2007: Orange County Register: "Bone cancer treatment wins UCI business plan contest[LINK]
  • May 11, 2007: Bone-Rad Therapeutics competes in the Orange County Register's People's Choice Award contest [LINK]
  • May 11, 2007: Watch the Bone-Rad Therapeutics elevator pitch [LINK]